CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Kawasaki Disease

  • A Patient with Kawasaki Disease Following Influenza Vaccinations. 📎

    facebook Share on Facebook
    Abstract Title:

    A Patient with Kawasaki Disease Following Influenza Vaccinations.

    Abstract Source:

    Pediatr Infect Dis J. 2015 Aug ;34(8):913. PMID: 26376188

    Abstract Author(s):

    Shuichiro Shimada, Toru Watanabe, Seiichi Sato

    Article Affiliation:

    Shuichiro Shimada

    Abstract:

    [n/a]

  • An infant presenting with Kawasaki disease following immunization for influenza: A case report. 📎

    facebook Share on Facebook
    Abstract Title:

    An infant presenting with Kawasaki disease following immunization for influenza: A case report.

    Abstract Source:

    Biomed Rep. 2018 Mar ;8(3):301-303. Epub 2018 Jan 16. PMID: 29564128

    Abstract Author(s):

    Seung Woo Jeong, Do Hee Kim, Mi Young Han, Sung-Ho Cha, Kyung Lim Yoon

    Article Affiliation:

    Seung Woo Jeong

    Abstract:

    Kawasaki disease (KD) is a childhood vascular disorder of unknown etiology. Concerns have recently been raised regarding vaccinations as a potential risk factor for KD. In addition, various forms of vasculitis have been reported as adverse events following administration after various vaccines. Patients exhibiting post vaccination KD have previously been described; however, thus far, to the best of our knowledge, only one patient exhibiting post influenza vaccination KD has been reported in Japan. The present study describes a case of KD 24 h after immunization with influenza in an infant (age, 18 months) following 6 days of high fever, a body rash that had persisted for 2 days and nonsuppurative bilateral conjunctivitis. To the best of the authors' knowledge, this is the first reported case in Korea and the present study reviews various recent studies regarding vasculitis following vaccination and the causal association between them.

  • Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease. 📎

    facebook Share on Facebook
    Abstract Title:

    Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.

    Abstract Source:

    BMJ Case Rep. 2016 Mar 31 ;2016. Epub 2016 Mar 31. PMID: 27033285

    Abstract Author(s):

    Cristina Novais, Fabiana Fortunato, Anabela Bicho, Luísa Preto

    Article Affiliation:

    Cristina Novais

    Abstract:

    Kawasaki disease (KD) is an acute, self-limited, systemic vasculitis of unknown aetiology, extremely rare in infants younger than 6 months old. Younger infants are more likely to present with incomplete KD (IKD) and are at higher risk of developing coronary abnormalities. An early and specific clinical sign, not included in the classical diagnosis criteria, but that can be very useful in the diagnosis of KD, is the reaction at the Bacillus Calmette-Guérin (BCG) inoculation site. We describe a case of a 4-month-old boy, fully immunised, whose BCG scar reactivation led to the diagnosis of IKD. This case-report emphasises the importance of BCG site reactivation in establishing a diagnosis of IKD that clinicians should be aware of, especially in countries where BCG vaccination is still part of the immunisation schedule.

  • Breastfeeding and Risk of Kawasaki Disease: A Nationwide Longitudinal Survey in Japan📎

    facebook Share on Facebook
    Abstract Title:

    Breastfeeding and Risk of Kawasaki Disease: A Nationwide Longitudinal Survey in Japan.

    Abstract Source:

    Pediatrics. 2016 Jun ;137(6). Epub 2016 May 11. PMID: 27244853

    Abstract Author(s):

    Takashi Yorifuji, Hirokazu Tsukahara, Hiroyuki Doi

    Article Affiliation:

    Takashi Yorifuji

    Abstract:

    BACKGROUND AND OBJECTIVES:Kawasaki disease (KD) is the most common cause of childhood-acquired heart disease in developed countries. However, the etiology of KD is not known. Aberrant immune responses are considered to play key roles in disease initiation and breastfeeding can mature immune system in infants. We thus examined the association between breastfeeding and the development of KD.

    METHODS:We used a nationwide population-based longitudinal survey ongoing since 2010 and restricted participants to a total of 37 630 children who had data on their feeding during infancy. Infant feeding practice was queried at 6 to 7 months of age, and responses to questions about hospital admission for KD during the period from 6 to 30 months of age were used as outcome. We conducted logistic regression analyses controlling for child and maternal factors with formula feeding without colostrum as our reference group.

    RESULTS:A total of 232 hospital admissions were observed. Children who were breastfed exclusively or partially were less likely to be hospitalized for KD compared with those who were formula fed without colostrum; odds ratios for hospitalization were 0.26 (95% confidence interval: 0.12-0.55) for exclusive breastfeeding and 0.27 (95% confidence interval: 0.13-0.55) for partial breastfeeding. Although the risk reduction was not statistically significant, feeding colostrum only also provided a protective effect.

    CONCLUSIONS:We observed protective effects of breastfeeding on the development of KD during the period from 6 to 30 months of age in a nationwide, population-based, longitudinal survey in Japan, the country in which KD is most common.

  • Kawasaki disease in an infant following immunisation with hepatitis B vaccine.

    Abstract Title:

    Kawasaki disease in an infant following immunisation with hepatitis B vaccine.

    Abstract Source:

    Clin Rheumatol. 2003 Dec ;22(6):461-3. Epub 2003 Oct 7. PMID: 14677029

    Abstract Author(s):

    Dan Miron, Daniel Fink, Philip J Hashkes

    Article Affiliation:

    Dan Miron

    Abstract:

    The known association between hepatitis B and vasculitis has been reported in rare cases in adults after hepatitis B vaccination. We here describe a 35-day-old infant who developed Kawasaki disease 1 day after receiving his second dose of hepatitis B vaccine. Although extremely rare, this possible side effect should be noted and further investigated.

  • The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report. 📎

    facebook Share on Facebook
    Abstract Title:

    The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report.

    Abstract Source:

    Hum Vaccin Immunother. 2015 ;11(11):2740-3. Epub 2015 Jul 9. PMID: 26158590

    Abstract Author(s):

    Shi Yin, Peng Liubao, Tan Chongqing, Wan Xiaomin

    Article Affiliation:

    Shi Yin

    Abstract:

    Kawasaki disease (KD) after rotavirus and hepatitis A vaccination has not previously been reported in a baby in China. Herein, we describe a 20-month-old child who developed Kawasaki disease after receiving her second dose of Lanzhou lamb rotavirus vaccine (LLR) and her first dose of freeze-dried live attenuated hepatitis A vaccine. The case report was conducted by collecting and analyzing the hospital in-patient medical records and reviewing both the domestic and foreign pertinent literature. These findings will be important to note this possible side effect and to further investigate the association between the above 2 vaccines and Kawasaki disease.

  • Two infants with tuberculid associated with Kawasaki disease. 📎

    Abstract Title:

    Two infants with tuberculid associated with Kawasaki disease.

    Abstract Source:

    Hum Vaccin Immunother. 2016 11 ;12(11):2772-2776. Epub 2016 Jul 19. PMID: 27435523

    Abstract Author(s):

    Hiroko Yamada, Haruka Ohta, Shunji Hasegawa, Yoshihiro Azuma, Masanari Hasegawa, Ryo Kadoya, Noriko Ohbuchi, Yuji Ohnishi, Seigo Okada, Madoka Hoshide, Shouichi Ohga

    Article Affiliation:

    Hiroko Yamada

    Abstract:

    Bacille de Calmette et Guerin (BCG) is the only licensed tuberculosis vaccine to prevent severe tuberculosis. The adverse events of BCG vaccination, including local reactions, lymphadenitis, osteomyelitis, tuberculid, and disseminated infection, have been reported. Two infants presented erythema at the inoculation site of BCG after the resolution of Kawasaki disease (K). They received BCG vaccination 1 week and 6 weeks before the Konset, respectively. Intravenous immunoglobulin improved the Kactivity, however the skin rash of BCG inoculation site extended to the face and extremities days 24 and 10 after the Konset, respectively. Both bacteriological study and interferon-γ release assay were negative for Mycobacterium tuberculosis infection. These patients were diagnosed as having tuberculid after K. The skin lesions gradually disappeared without antibiotic therapy over 2 months. The development of tuberculid in these patients might be associated with the remnant immune activation of K.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.